Chemical activators of Vmn2r10 can be a diverse group of compounds that primarily exert their effects by increasing intracellular cyclic adenosine monophosphate (cAMP) levels, which in turn activate Vmn2r10 through secondary messenger pathways. Forskolin directly activates adenylate cyclase, the enzyme responsible for the conversion of ATP to cAMP. This increase in cAMP levels can lead to the activation of protein kinase A (PKA), which then phosphorylates various proteins, potentially including Vmn2r10. Similarly, isoproterenol, acting as a beta-adrenergic agonist, and adrenaline and noradrenaline, engaging adrenergic receptors, all contribute to elevated intracellular cAMP, which serves as a second messenger to relay signals for the activation of Vmn2r10.
Additionally, dopamine, by binding to its specific receptors, can initiate a signaling cascade that results in increased cAMP levels and subsequent activation of Vmn2r10. Glucagon, functioning through its own receptor, can also cause an increase in cAMP, which is known to stimulate Vmn2r10 activation. Histamine, through H2 receptor activation, has a similar effect in raising cAMP levels, thereby activating Vmn2r10. Inhibitors of phosphodiesterases such as IBMX, anagrelide, and rolipram, prevent the degradation of cAMP, thus sustaining an activated state of Vmn2r10 due to elevated cAMP. PGE1, through receptor-mediated action, can elevate cAMP production, which further supports the activation of Vmn2r10. Lastly, cholera toxin, by permanently activating the Gs alpha subunit, leads to continuous stimulation of adenylate cyclase which results in persistently high levels of cAMP, thus maintaining Vmn2r10 in an active state. Each of these chemicals, through their action on cAMP levels and signaling, has the potential to functionally activate Vmn2r10.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Functions as a beta-adrenergic agonist, increasing intracellular cAMP which activates Vmn2r10 via downstream cAMP-dependent processes. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Binds to dopamine receptors which can increase cAMP levels, leading to the activation of Vmn2r10 through cAMP signaling cascades. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Engages adrenergic receptors, raising cAMP levels, and can activate Vmn2r10 through cAMP-mediated pathways. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Acts on adrenergic receptors to increase cAMP, which in turn can activate Vmn2r10 through secondary messenger pathways. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Through H2 receptor activation, it can increase cAMP levels which lead to the activation of Vmn2r10 via cAMP-mediated signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases that prevents cAMP degradation, thus can activate Vmn2r10 by maintaining high levels of cAMP. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Selectively inhibits phosphodiesterase III, increasing cAMP levels which can activate Vmn2r10 through the cAMP/PKA signaling pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Inhibits phosphodiesterase 4, leading to increased cAMP levels which can activate Vmn2r10 through cAMP-dependent signaling. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Elevates cAMP production through its receptor-mediated action which can activate Vmn2r10 downstream of cAMP signaling. | ||||||